Anti-CD52 Therapy in Experimental Autoimmune Encephalomyelitis

被引：0
|
作者：
Turner, Michael J.
Chretien, Nathalie
Havari, Evis
LaMorte, Michael
Roberts, Bruce
Kaplan, Johanne
Siders, William M.
机构：
来源：
ANNALS OF NEUROLOGY | 2012年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [1] Anti-CD52 therapy in experimental autoimmune encephalomyelitis
    Turner, Mike
    Chretien, Nathalie
    Havari, Evis
    LaMorte, Michael
    Roberts, Bruce
    Kaplan, Johanne
    Siders, William
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [2] Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis
    Turner, Michael J.
    Pang, Petti T.
    Chretien, Nathalie
    Havari, Evis
    LaMorte, Michael J.
    Oliver, Julian
    Pande, Nilesh
    Masterjohn, Elizabeth
    Carter, Karen
    Reczek, David
    Brondyk, William
    Roberts, Bruce L.
    Kaplan, Johanne M.
    Siders, William M.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 285 : 4 - 12
  • [3] Activity of an Anti-Murine CD52 Antibody in Experimental Autoimmune Encephalomyelitis
    Turner, Michael
    Chretien, Nathalie
    Havari, Evis
    LaMorte, Michael
    Roberts, Bruce
    Kaplan, Johanne
    Siders, William
    NEUROLOGY, 2012, 78
  • [4] The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels
    Barbour, Mark
    Wood, Rachel
    Hridi, Shehla U.
    Wilson, Chelsey
    Mckay, Grant
    Bushell, Trevor J.
    Jiang, Hui-Rong
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 318 : 87 - 96
  • [5] Preservation of lymphocyte migratory ability following anti-CD52 therapy
    Turner, M. J.
    Havari, E.
    Dodge, J.
    Treleaven, C.
    Shihabuddin, L.
    Roberts, B.
    Kaplan, J.
    Siders, W. M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 573 - 573
  • [6] Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
    Kasarello, Kaja
    Mirowska-Guzel, Dagmara
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 237 - 246
  • [7] Anti-CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems
    Barbour, Mark
    Wood, Rachel
    Harte, Tanith
    Bushell, Trevor J.
    Jiang, Hui-Rong
    IMMUNOLOGY, 2022, 165 (03) : 312 - 327
  • [8] Histopathologic spectrum of hypersensitivity reactions associated with anti-CD52 therapy (alemtuzumab)
    Clark, Stacie L.
    Tse, Julie Y.
    Fisher, David C.
    LeBeouf, Nicole R.
    Murphy, George F.
    Kupper, Thomas S.
    Clark, Rachael A.
    Lian, Christine G.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (11) : 989 - 993
  • [9] In vivo efficacy of anti-Cd52 antibody in Atll
    Ghez, D
    Suarez, F
    Delarue, R
    Aouba, A
    Hermine, O
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) : 468 - 468
  • [10] Targeting the SIV reservoir with alemtuzumab (anti-CD52)
    Chaunzwa, Morgan
    Varco-Merth, Benjamin
    Duell, Derick
    Marenco, Alejandra
    Docken, Steffen
    Smedley, Jeremy
    Axthelm, Michael K.
    Hansen, Scott G.
    Davenport, Miles P.
    Estes, Jacob D.
    Keele, Brandon
    Lifson, Jeffrey D.
    Lewin, Sharon R.
    Okoye, Afam A.
    Picker, Louis J.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2023, 52 (05) : 309 - 309
12345